Our Team
Three directors. Three disciplines.
Each of us brings a distinct expertise. Together, we cover the full spectrum of what STEM startups need to succeed.
Every STEM startup faces a complex web of scientific, commercial, and financial challenges. We have particular depth in healthtech, medtech, and diagnostics. We bring together expertise that most firms cannot offer under one roof.
Most consultancies send junior analysts with a playbook. We are three directors with two PhDs, a US patent, peer-reviewed publications, and our own exits behind us. We do the work ourselves.
Two-thirds of our team hold PhDs from world-leading universities. We combine deep technical fluency with the commercial and financial acumen to translate innovation into funded, market-ready products.
We've founded, funded, and exited our own ventures. Traded derivatives at Goldman Sachs. Led translational science at a leading global pharmaceutical company. Designed landmark buildings across three continents. We advise from experience, not theory.
We integrate with your team for as long as you need us. We attend your board meetings, join your investor calls, and work alongside your engineers. We succeed when you succeed.
We have built, launched, and regulated AI-driven products in clinical environments. From CE-marked oncology biomarkers to FDA-cleared imaging tools, we understand what it takes to get AI products through development, validation, and to market. We help our clients do the same.
Each of us brings a distinct expertise. Together, we cover the full spectrum of what STEM startups need to succeed.
Your deck, model and round logic tested the way an investor would, with a written, prioritised list of what to fix before you raise.
See what is included →Your likely classification, pathway options, evidence gaps and timeline across the UK, EU and US, plus an investor-ready regulatory narrative.
See what is included →
